Phibro Animal Health (PAHC) Shares Outstanding (Weighted Average) (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Shares Outstanding (Weighted Average) of $40.6 million in Q1 2026, little changed quarter-over-quarter from $40.5 million in Q4 2025, and little changed on a YoY basis from $40.5 million in Q1 2025.
Phibro Animal Health (PAHC) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends
Phibro Animal Health's Shares Outstanding (Weighted Average) history runs 14 years deep, the most recent figure standing at $40.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) changed 0.1% year-over-year to $40.6 million; the TTM figure through Mar 2026 stood at $40.6 million (changed 0.1% YoY), while the FY2025 annual figure was $40.5 million, changed 0.03% from the prior year.
- Shares Outstanding (Weighted Average) was $40.6 million for Q1 2026 at Phibro Animal Health, roughly flat from $40.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.6 million in Q1 2026 to a low of $40.5 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $40.5 million across 5 years, with a median of $40.5 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) changed 0.0% in 2022, then gained 0.1% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $40.5 million in 2022, then changed by 0.0% to $40.5 million in 2023, then changed by 0.0% to $40.5 million in 2024, then climbed by 0.07% to $40.5 million in 2025, then rose by 0.04% to $40.6 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $40.6 million (Q1 2026), $40.5 million (Q4 2025), and $40.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 100.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 5.11 Bn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 88.01 Mn |
| 10 | Phibro Animal Health | 1.29 Bn | 1.22 Bn | 125.68 Mn | 40.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.55 Mn |
| Dec 31, 2025 | 40.53 Mn |
| Sep 30, 2025 | 40.53 Mn |
| Jun 30, 2025 | 40.52 Mn |
| Mar 31, 2025 | 40.51 Mn |
| Dec 31, 2024 | 40.50 Mn |
| Sep 30, 2024 | 40.50 Mn |
| Jun 30, 2024 | 40.50 Mn |
| Mar 31, 2024 | 40.50 Mn |
| Dec 31, 2023 | 40.50 Mn |
| Sep 30, 2023 | 40.50 Mn |
| Jun 30, 2023 | 40.50 Mn |
| Mar 31, 2023 | 40.50 Mn |
| Dec 31, 2022 | 40.50 Mn |
| Sep 30, 2022 | 40.50 Mn |
| Jun 30, 2022 | 40.50 Mn |
| Mar 31, 2022 | 40.50 Mn |
| Dec 31, 2021 | 40.50 Mn |
| Sep 30, 2021 | 40.50 Mn |
| Jun 30, 2021 | 40.47 Mn |